Clinical trial NCT00027859 - References

Prostate Cancer — Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

Citation(s)

•   Walczak JR, Carducci MA; Eastern Cooperative Oncology Group E1899
  Phase 3 randomized trial evaluating second-line hormonal therapy versus docetaxel-estramustine combination chemotherapy on progression-free survival in asymptomatic patients with a rising

A Phase III Randomized Trial for Evaluating Second Line Hormonal Therapy (Ketoconazole/Hydrocortisone) Versus Paclitaxel/Estramustine Combination Chemotherapy on Progression Free Survival in Asymptomatic Patients With a Rising PSA After Hormonal Therapy for Prostate Cancer

Details for clinical trial NCT00027859